Senate Drug Import Bill Would Require Notice Of Manufacturing Changes

Drug manufacturers would be required to notify FDA of any manufacturing changes that might serve to circumvent reimportation under bipartisan legislation introduced by Sens. Byron Dorgan (D-N.D.) and Edward Kennedy (D-Mass.) April 21